{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:06:11Z","timestamp":1776326771269,"version":"3.50.1"},"reference-count":31,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Thai society of Hematology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology Reports"],"abstract":"<jats:p>Objective: To describe the epidemiology, survival rate, and prognostic factors of mucosal-associated lymphoid tissue (MALT) lymphoma. Patients and Methods: This investigation utilized the Thai Lymphoma Study Group (TLSG) registry to gather data on patients diagnosed with MALT lymphoma. The analysis included demographic details, therapeutic interventions, and survival statistics. Results: The TLSG registry prospectively included 8404 patients with lymphoma. Among them, marginal-zone lymphoma (MZL) was the second most common subtype, with 670 histologically confirmed cases, accounting for 8.0% of the total cohort. An analysis of the MZL subtypes showed that MALT lymphoma was the most common, accounting for 77.8% of the diagnoses. This was followed by nodal MZL at 17.5% and splenic MZL at 7.7%. The distribution of primary disease sites indicated that the ocular adnexa (49.2%), stomach (12.9%), and sinonasal region (12.5%) were the three most common locations. Three variables were found to be statistically significant predictors of survival in the multivariate analysis: ECOG performance status &gt; 2, age exceeding 65 years, and involvement of more than two extranodal organs. These identified prognostic factors were further assessed for their effect on overall survival (OS) and progression-free survival (PFS). A risk classification was established: the low-risk group comprised patients with zero identified risk factors, whereas the high-risk group included patients who had any of the specified risk factors. A comparison of five-year survival rates showed significantly more favorable outcomes for low-risk patients who had a PFS of 83.3% (vs. 66.1%, p = 0.028) and an OS of 97.8% (vs. 76.7%, p &lt; 0.001) compared to the high-risk group. Conclusions: In this cohort, where MZL was the second most common lymphoma and MALT lymphoma was the predominant subtype, our analysis revealed that patients with no risk factors experienced statistically significant improvements in both PFS and OS.<\/jats:p>","DOI":"10.3390\/hematolrep17060063","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T10:46:18Z","timestamp":1764067578000},"page":"63","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mucosal-Associated Lymphoid Tissue Lymphoma in Southeast Asia: A 15-Year Retrospective Multicenter Study"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3447-7600","authenticated-orcid":false,"given":"Kannadit","family":"Prayongratana","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok 10400, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0528-4076","authenticated-orcid":false,"given":"Tanapun","family":"Thamgrang","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok 10400, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chonlada","family":"Laoruangroj","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok 10400, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalita","family":"Norasetthada","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 52000, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanawat","family":"Rattanathammethee","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 52000, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udomsak","family":"Bunworasate","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kitsada","family":"Wudhikarn","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6526-9479","authenticated-orcid":false,"given":"Jakrawadee","family":"Julamanee","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panarat","family":"Noiperm","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suporn","family":"Chuncharunee","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pimjai","family":"Niparuck","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archrob","family":"Khuhapinant","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8624-5516","authenticated-orcid":false,"given":"Noppadol","family":"Siritanaratkul","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyapong","family":"Kanya","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Chiang Rai Prachanukroh, Chiang Rai 57000, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanchana","family":"Chansung","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chittima","family":"Sirijerachai","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dusit","family":"Jit-Uaekul","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Faculty of Medicine, Vajira Hospital, Bangkok 10300, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juthatip","family":"Chaloemwong","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Nakornping Hospital, Chiang Mai 50180, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonglak","family":"Kanitsap","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Thammasat University, Pathumthani 12121, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peerapon","family":"Wong","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Naresuan University, Phitsanulok 65000, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4003-1061","authenticated-orcid":false,"given":"Nisa","family":"Makruasi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Srinakharinwirot University, Nakhon Nayok 26120, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somchai","family":"Wongkhantee","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Khon Kaen Regional Hospital, Khon Kaen 40000, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tawatchai","family":"Suwanban","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Rajavithi Hospital, Bangkok 10400, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanin","family":"Intragumtornchai","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin\u2019s lymphomas: Clinical features of the major histologic subtypes. Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"16","author":"Armitage","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11864-019-0687-5","article-title":"Marginal Zone Lymphoma: State-of-the-Art Treatment","volume":"20","author":"Sindel","year":"2019","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/annonc\/mdp402","article-title":"Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pylori interventions: Results from a population-based study on extranodal marginal zone lymphomas","volume":"21","author":"Luminari","year":"2010","journal-title":"Ann. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.beha.2016.07.002","article-title":"Epidemiology and environmental aspects of marginal zone lymphomas","volume":"30","author":"Sriskandarajah","year":"2017","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/aol-20-28","article-title":"Epidemiology of Marginal Zone Lymphoma","volume":"5","author":"Cerhan","year":"2021","journal-title":"Ann. Lymphoma"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"The Non-Hodgkin\u2019s Lymphoma Classification Project (1997). A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification Project. Blood, 89, 3909\u20133918.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/ajh.27058","article-title":"Marginal zone lymphoma: 2023 update on diagnosis and management","volume":"98","author":"Cheah","year":"2023","journal-title":"Am. J. Hematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood-2015-12-624304","article-title":"The spectrum of MALT lymphoma at different sites: Biological and therapeutic relevance","volume":"127","author":"Zucca","year":"2016","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.beha.2016.09.002","article-title":"MALT lymphoma: Genetic abnormalities, immunological stimulation and molecular mechanism","volume":"30","author":"Du","year":"2017","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1440-1827.2007.02128.x","article-title":"Mucosa-associated lymphoid tissue lymphoma: Molecular pathogenesis and clinicopathological significance","volume":"57","author":"Inagaki","year":"2007","journal-title":"Pathol. Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/hon.2392","article-title":"Non-Hodgkin lymphoma in South East Asia: An analysis of the histopathology, clinical features, and survival from Thailand","volume":"36","author":"Intragumtornchai","year":"2018","journal-title":"Hematol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/sim.7992","article-title":"Minimum sample size for developing a multivariable prediction model: PART II\u2014Binary and time-to-event outcomes","volume":"38","author":"Riley","year":"2019","journal-title":"Stat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/ajh.26715","article-title":"Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma","volume":"97","author":"Alderuccio","year":"2022","journal-title":"Am. J. Hematol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Bursac, Z., Gauss, C.H., Williams, D.K., and Hosmer, D.W. (2008). Purposeful selection of variables in logistic regression. Source Code Biol. Med., 3.","DOI":"10.1186\/1751-0473-3-17"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1309\/AJCP7YLTQPUSDQ5C","article-title":"Distribution of lymphoid neoplasms in China: Analysis of 4,638 cases according to the World Health Organization classification","volume":"138","author":"Sun","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3904\/kjim.2010.25.3.227","article-title":"Non-gastric marginal zone B-cell lymphoma in Korea: Clinical features, treatment, and prognostic factors","volume":"25","author":"Oh","year":"2010","journal-title":"Korean J. Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/annonc\/mdm513","article-title":"Ocular adnexal MALT lymphoma: An intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy","volume":"19","author":"Ferreri","year":"2008","journal-title":"Ann. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","article-title":"Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas","volume":"96","author":"Ferreri","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5045\/br.2018.53.4.307","article-title":"Clinical presentation and treatment outcomes of primary ocular adnexal MALT lymphoma in Thailand","volume":"53","author":"Seresirikachorn","year":"2018","journal-title":"Blood Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11960","DOI":"10.1182\/blood-2022-168346","article-title":"Epidemiology and Prognostic Index of Ocular Adnexal Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) in Thailand: Results from the Thai Lymphoma Study Group (TLSG)","volume":"140","author":"Thamgrang","year":"2022","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","article-title":"Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue","volume":"101","author":"Zucca","year":"2003","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","article-title":"Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed","volume":"95","author":"Thieblemont","year":"2000","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3324\/haematol.11835","article-title":"Dissemination patterns in non-gastric MALT lymphoma","volume":"93","author":"Hiddink","year":"2008","journal-title":"Haematologica"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1182\/blood-2017-03-771915","article-title":"A MALT lymphoma prognostic index","volume":"130","author":"Thieblemont","year":"2017","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1200\/JCO.2016.70.6994","article-title":"Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival with Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy","volume":"35","author":"Zucca","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Alderuccio, J.P., Florindez, J.A., Reis, I.M., Zhao, W., and Lossos, I.S. (2021). Treatments and Outcomes in Stage I Extranodal Marginal Zone Lymphoma in the United States. Cancers, 13.","DOI":"10.3390\/cancers13081803"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0277-5379(82)90242-5","article-title":"Serum lactate dehydrogenase (LDH) as a prognostic index for non-Hodgkin\u2019s lymphoma","volume":"18","author":"Endrizzi","year":"1982","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13045-023-01448-y","article-title":"Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study","volume":"16","author":"Epperla","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1182\/blood.2019001088","article-title":"Early progression as a predictor of survival in marginal zone lymphomas: An analysis from the FIL-NF10 study","volume":"134","author":"Luminari","year":"2019","journal-title":"Blood"}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2038-8330\/17\/6\/63\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T11:44:24Z","timestamp":1764071064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/17\/6\/63"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["hematolrep17060063"],"URL":"https:\/\/doi.org\/10.3390\/hematolrep17060063","relation":{},"ISSN":["2038-8330"],"issn-type":[{"value":"2038-8330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]}}}